Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis
- PMID: 33593743
- PMCID: PMC8070630
- DOI: 10.1136/archdischild-2020-321385
Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis
Abstract
Objective: Compare paediatric COVID-19 disease characteristics, management and outcomes according to World Bank country income level and disease severity.
Design: Systematic review and meta-analysis.
Setting: Between 1 December 2019 and 8 January 2021, 3350 articles were identified. Two reviewers conducted study screening, data abstraction and quality assessment independently and in duplicate. Observational studies describing laboratory-confirmed paediatric (0-19 years old) COVID-19 were considered for inclusion.
Main outcomes and measures: The pooled proportions of clinical findings, treatment and outcomes were compared according to World Bank country income level and reported disease severity.
Results: 129 studies were included from 31 countries comprising 10 251 children of which 57.4% were hospitalised. Mean age was 7.0 years (SD 3.6), and 27.1% had a comorbidity. Fever (63.3%) and cough (33.7%) were common. Of 3670 cases, 44.1% had radiographic abnormalities. The majority of cases recovered (88.9%); however, 96 hospitalised children died. Compared with high-income countries, in low-income and middle-income countries, a lower proportion of cases were admitted to intensive care units (ICUs) (9.9% vs 26.0%) yet pooled proportion of deaths among hospitalised children was higher (relative risk 2.14, 95% CI 1.43 to 3.20). Children with severe disease received antimicrobials, inotropes and anti-inflammatory agents more frequently than those with non-severe disease. Subgroup analyses showed that a higher proportion of children with multisystem inflammatory syndrome (MIS-C) were admitted to ICU (47.1% vs 22.9%) and a higher proportion of hospitalised children with MIS-C died (4.8% vs 3.6%) compared with the overall sample.
Conclusion: Paediatric COVID-19 has a favourable prognosis. Further severe disease characterisation in children is needed globally.
Keywords: COVID-19; adolescent health; epidemiology.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
References
-
- WHO . Who coronavirus disease (COVID-19) Dashboard data last updated: 2021/1/21. Available: https://covid19.who.int/
-
- Dong Y, Mo X, Hu Y. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. J Emerg Med 2020;58:712–3. 10.1016/j.jemermed.2020.04.006 - DOI
-
- AAP . Children and COVID19: state data report 28/8/2020, 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical